Avoid makeup, active skincare (vitamin C, retinol, AHAs/BHAs), direct sun, and strenuous exercise
This milestone represents a meaningful shift in Novo Nordisk recently received FDA approval to bring its oral semaglutide formulation, Rybelsus, under the Ozempic brand aligning oral and injectable semaglutide for type 2 diabetes under a single, highly recognized name On February 24, 2026, Novo Nordisk announced it will significantly reduce the wholesale acquisition cost (WAC) of several of its GLP1 therapies, effective January 1, 2027 On February 20, 2026 the U.S
Access and cost: Prescription GLP-1 medications require a provider visit, eligibility assessment, and ongoing monitoring
Acta Biomater 148:230243
Geneva also offers a dedicated Telemedicine Program for patients who want to manage follow-ups, medication adjustments, and weight-loss coaching from home
As always, its a pleasure to talk to you